tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CDTX is currently covered by 4 analysts with an average price target of $170.5. This is a potential downside of $50.88 (-22.98%) from yesterday's end of day stock price of $221.38.
Cidara Therapeutics's activity chart (see below) currently has 106 price targets and 97 ratings on display. The stock rating distribution of CDTX is 83.33% BUY and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 78.45% with an average time for these price targets to be met of 507.88 days.
Highest price target for CDTX is $221.5, Lowest price target is $145, average price target is $170.5.
Most recent stock forecast was given by MAXWELL SKOR from MORGAN STANLEY on 23-Nov-2025. First documented stock forecast 11-May-2015.
Currently out of the existing stock ratings of CDTX, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Nov-2025
$221.5
$0.12 (0.05%)
11 months 8 days ago
(23-Nov-2025)
1/2 (50%)
$2.15 (0.98%)
29
Buy Since 08-Nov-2024
$167
11 months 13 days ago
(18-Nov-2025)
7/7 (100%)
$82.24 (97.03%)
82
Buy Since 08-Mar-2022
$135
11 months 17 days ago
(14-Nov-2025)
15/15 (100%)
$30.61 (29.32%)
475
Buy Since 26-Sep-2025
$150
11 months 17 days ago
(14-Nov-2025)
2/2 (100%)
$46.78 (45.32%)
19
Buy Since 24-Jun-2025
$145
$-76.38 (-34.50%)
$115
11 months 24 days ago
(07-Nov-2025)
3/3 (100%)
$40.61 (38.90%)
55
What is CDTX (Cidara Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CDTX (Cidara Therapeutics)?
Which analyst has the most public recommendations on CDTX (Cidara Therapeutics)?
Which analyst is the currently most bullish on CDTX (Cidara Therapeutics)?
Which analyst is the currently most reserved on CDTX (Cidara Therapeutics)?
